Cannell & Spears’s Amrize Ltd AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Sell
30,857
-1,021
-3% -$58.5K 0.03% 205
2025
Q4
$1.72M Sell
31,878
-1,068,205
-97% -$54.5M 0.03% 200
2025
Q3
$53.4M Buy
+1,100,083
New +$56.1M 1.01% 23

Other funds holding AMRZ

Cannell & Spears's AMRZ Position: Q1 2026 in Review

Cannell & Spears reduced its Amrize Ltd (AMRZ) stake by 3.2% in Q1 2026, selling an estimated $58.5K and leaving 30,857 shares worth $1.73M. The position accounts for 0.03% of the portfolio, ranked #205.

Cannell & Spears first reported a position in AMRZ in Q3 2025 and has held it in 3 quarters since. The position peaked at $53.4M in Q3 2025. 447 funds tracked by Wall St. Rank hold AMRZ as of Q1 2026.

  • Cannell & Spears held 30,857 shares of Amrize Ltd worth $1.73M as of Q1 2026.
  • Cannell & Spears sold 1,021 Amrize Ltd shares in Q1 2026, an estimated $58.5K.
  • Amrize Ltd made up 0.03% of Cannell & Spears's portfolio in Q1 2026, its #205 holding.
  • Cannell & Spears first reported a position in Amrize Ltd in Q3 2025 and has held it in 3 quarters since.
  • Cannell & Spears's Amrize Ltd position peaked at $53.4M in Q3 2025.
  • 447 funds tracked by Wall St. Rank held Amrize Ltd as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.